5-(4-amino-1-propan-2-yl-3-pyrazolo[3-4-d]pyrimidinyl)-1-3-benzoxazol-2-amine and Malaria

5-(4-amino-1-propan-2-yl-3-pyrazolo[3-4-d]pyrimidinyl)-1-3-benzoxazol-2-amine has been researched along with Malaria* in 1 studies

Other Studies

1 other study(ies) available for 5-(4-amino-1-propan-2-yl-3-pyrazolo[3-4-d]pyrimidinyl)-1-3-benzoxazol-2-amine and Malaria

ArticleYear
Repurposing sapanisertib in malaria.
    Nature reviews. Drug discovery, 2022, Volume: 21, Issue:12

    Topics: Drug Repositioning; Humans; Malaria; Pyrazoles; Pyrimidines

2022